CBD can cause liver injury, and this isn’t speculation. The FDA flagged liver damage as a specific safety risk during its review of the only approved CBD drug, and clinical trials have confirmed that CBD at certain doses elevates liver enzymes, a marker of liver stress. The real question is how much risk everyday CBD use actually carries, and that depends heavily on dose, other medications, and your liver’s baseline health.
How CBD Gets Processed in Your Liver
Your liver does the heavy lifting when it comes to breaking down CBD. After you swallow a CBD product, liver enzymes called cytochrome P450 enzymes, specifically CYP2C19, CYP2C9, and CYP3A4, oxidize the compound into several metabolites. The main active one is called 7-hydroxy-CBD, which your body then converts into an inactive form and clears out. A second set of liver enzymes handles a parallel breakdown pathway.
This is significant for two reasons. First, your liver is working every time you take CBD. At low doses, that workload is manageable. At higher doses, or with repeated daily use, the strain on these enzyme systems increases. Second, because CBD competes for the same enzymes that process many common medications, it can create a bottleneck that stresses liver cells beyond what either substance would cause alone.
What Clinical Trials Have Found
The clearest liver safety data comes from trials of Epidiolex, the prescription CBD product approved for severe seizure disorders. During those trials, a meaningful percentage of participants developed elevated liver transaminases, the enzymes that leak into the bloodstream when liver cells are damaged or inflamed. These elevations were detected through routine blood tests, not symptoms, meaning people had no idea their livers were under stress until lab work revealed it.
The FDA’s review was direct: CBD can cause liver injury, and signs of that injury appeared even in patients who were not taking other liver-taxing drugs. The risk was higher in people who were, but it wasn’t limited to them.
A more recent randomized clinical trial published in JAMA Internal Medicine tested CBD at 5 mg/kg daily (split into two doses) in 151 healthy adults over 28 days. That dosage sits at the higher end of what consumers typically take with over-the-counter products but falls within the reported range of real-world use. The study was specifically designed to see whether consumer-level dosing, not just the higher clinical doses used for epilepsy, could affect liver enzymes.
The Dose Question
Prescription CBD for epilepsy is dosed at 10 to 20 mg/kg per day, sometimes higher. For a 150-pound person, that works out to roughly 680 to 1,360 mg daily. Most consumer CBD products suggest servings between 10 and 50 mg, which is a fraction of that clinical dose. This gap matters because liver risk appears to scale with dose: higher amounts of CBD mean more enzyme stress.
That said, “low dose means low risk” isn’t a guarantee. Consumer CBD products are unregulated, and independent testing has repeatedly found that the actual CBD content doesn’t always match the label. Some products contain significantly more CBD than advertised. Others contain contaminants that could add their own liver burden. Without standardized manufacturing or FDA oversight, you can’t be certain what dose you’re actually taking.
Medications That Raise the Risk
The most well-documented dangerous combination is CBD with valproate, a drug commonly prescribed for epilepsy and mood disorders. In clinical trials, about 16% of patients taking both CBD and valproate developed elevated liver enzymes, a rate substantially higher than either drug alone. The interaction appears to be dose-dependent: the more CBD, the greater the risk.
But valproate isn’t the only concern. Because CBD is processed by the same CYP2C19, CYP2C9, and CYP3A4 enzymes that metabolize a long list of common drugs, including certain blood thinners, antidepressants, statins, and antifungals, there is potential for similar bottleneck effects. When two substances compete for the same enzyme, both can linger in the body longer than expected, raising the effective dose of each and increasing the chance of liver cell damage.
Who Faces the Most Risk
People with pre-existing liver disease are at the top of the risk list. If your liver is already compromised by fatty liver disease, hepatitis, cirrhosis, or heavy alcohol use, its capacity to safely metabolize CBD is reduced. Research has noted that the hepatotoxic potential of CBD is heightened in people with existing liver conditions, in children, and in older adults, all of whom may process CBD differently than a healthy middle-aged adult.
People taking multiple medications face compounded risk because of the enzyme competition described above. And anyone using high-dose CBD products daily over extended periods is accumulating more liver workload than someone taking an occasional low dose. The combination of pre-existing liver vulnerability, other medications, and higher CBD doses creates a scenario where liver injury becomes a real possibility rather than a theoretical one.
What the FDA’s Position Means for You
The FDA has stated plainly that CBD can cause liver injury and that this risk is manageable under medical supervision but “less clear how it might be managed when CBD is used far more widely, without medical supervision.” The agency has not approved any over-the-counter CBD product as a food additive or dietary supplement, and it considers marketing CBD in those forms illegal.
This doesn’t mean every person who takes a CBD gummy will develop liver problems. It means the safety profile of CBD at consumer doses, taken over months or years, simply hasn’t been established through the kind of rigorous long-term studies that would settle the question. The liver injury seen in clinical trials was typically caught early through blood tests and was reversible once CBD was stopped or the dose was lowered. But most people buying CBD at a dispensary or online are not getting regular liver function tests.
If you use CBD regularly, periodic blood work that includes a liver panel is a reasonable precaution, especially if you take other medications or have any history of liver problems. The early signs of CBD-related liver stress are usually invisible. By the time symptoms like fatigue, nausea, or dark urine appear, the damage may be more significant than what routine monitoring would have caught.